Search Results

There are 4771 results for: content related to: Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes

  1. Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation

    Journal of Cellular Biochemistry

    Volume 114, Issue 8, August 2013, Pages: 1819–1831, Nian-Kang Sun, Shang-Lang Huang, Ting-Chang Chang and Chuck C.-K. Chao

    Version of Record online : 11 JUN 2013, DOI: 10.1002/jcb.24530

  2. You have free access to this content
    Nuclear factor kappa B–mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice

    Hepatology

    Volume 62, Issue 2, August 2015, Pages: 534–545, Jessica Lo, Eunice Yuen Ting Lau, Rachel Hiu Ha Ching, Bowie Yik Ling Cheng, Mark Kin Fai Ma, Irene Oi Lin Ng and Terence Kin Wah Lee

    Version of Record online : 3 JUN 2015, DOI: 10.1002/hep.27859

  3. You have full text access to this Open Access content
    Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 8b, August 2009, Pages: 2673–2683, Hung Huynh, Van Chanh Ngo, Heng Nung Koong, Donald Poon, Su Pin Choo, Choon Hua Thng, Pierce Chow, Hock Soo Ong, Alexander Chung and Khee Chee Soo

    Version of Record online : 11 FEB 2009, DOI: 10.1111/j.1582-4934.2009.00692.x

  4. You have free access to this content
    Effects of Antitumor Drug Sorafenib on Chick Embryo Development

    The Anatomical Record

    Volume 298, Issue 7, July 2015, Pages: 1271–1281, Yi-Sen Cheng, Xiao-Yu Wang, Guang Wang, Yan Li, Yue-Lei Chen, Man-li Chuai, Kenneth Ka Ho Lee, Xiao-Yan Ding and Xue-song Yang

    Version of Record online : 17 APR 2015, DOI: 10.1002/ar.23155

  5. You have full text access to this OnlineOpen article
    Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1434–1444, Floris H. Groenendijk, Wouter W. Mellema, Eline van der Burg, Eva Schut, Michael Hauptmann, Hugo M. Horlings, Stefan M. Willems, Michel M. van den Heuvel, Jos Jonkers, Egbert F. Smit and René Bernards

    Version of Record online : 8 AUG 2014, DOI: 10.1002/ijc.29113

  6. You have free access to this content
    A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options

    BJU International

    Volume 107, Issue 8, April 2011, Pages: 1190–1199, Joaquim Bellmunt, Tim Eisen, Cezary Szczylik, Peter Mulders and Camillo Porta

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09829.x

  7. You have free access to this content
    Incidence and Risk of Sorafenib-Induced Hypertension: A Systematic Review and Meta-Analysis

    The Journal of Clinical Hypertension

    Volume 16, Issue 3, March 2014, Pages: 177–185, Yan Li, Shun Li, Yaofeng Zhu, Xinyue Liang, Hui Meng, Jun Chen, Dongqing Zhang, Hu Guo and Benkang Shi

    Version of Record online : 12 MAR 2014, DOI: 10.1111/jch.12273

  8. Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma

    Hepatology Research

    Volume 44, Issue 3, March 2014, Pages: 302–312, Haruhiko Takeda, Hiroki Nishikawa, Eriko Iguchi, Yoshiaki Ohara, Azusa Sakamoto, Sumio Saito, Norihiro Nishijima, Akihiro Nasu, Hideyuki Komekado, Ryuichi Kita, Toru Kimura and Yukio Osaki

    Version of Record online : 29 APR 2013, DOI: 10.1111/hepr.12125

  9. You have free access to this content
    Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib – the role of extracellular signal-regulated kinase counteraction

    The FEBS Journal

    Volume 278, Issue 18, September 2011, Pages: 3494–3507, Irena Manov, Yulia Pollak, Rinata Broneshter and Theodore C. Iancu

    Version of Record online : 5 SEP 2011, DOI: 10.1111/j.1742-4658.2011.08271.x

  10. Nutlin-3 enhances sorafenib efficacy in renal cell carcinoma

    Molecular Carcinogenesis

    Volume 52, Issue 1, January 2013, Pages: 39–48, Rit Vatsyayan, Jyotsana Singhal, Lokesh Dalasanur Nagaprashantha, Sanjay Awasthi and Sharad S. Singhal

    Version of Record online : 17 OCT 2011, DOI: 10.1002/mc.20875

  11. Phase I Trial of Sorafenib in Combination With 5-Fluorouracil/Leucovorin in Advanced Solid Tumors

    The Journal of Clinical Pharmacology

    Volume 52, Issue 5, May 2012, Pages: 656–669, Dr Einat Shacham-Shmueli, Dr Ravit Geva, Dr Arie Figer, Dr Sarah Bulocinic, Dr Karen Nalbandyan, Dr Shulim Shpigel, Dr Jacob Atsmon and Dr Erich Brendel

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011404027

  12. Inhibition of myeloid cell leukemia-1: Association with sorafenib-induced apoptosis in human mucoepidermoid carcinoma cells and tumor xenograft

    Head & Neck

    Volume 37, Issue 9, September 2015, Pages: 1326–1335, Hyun-Ju Yu, Ji-Ae Shin, Ji-Youn Jung, Jeong-Seok Nam, In-Sun Hong, Nam-Pyo Cho and Sung-Dae Cho

    Version of Record online : 19 JUL 2014, DOI: 10.1002/hed.23749

  13. You have free access to this content
    EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib

    International Journal of Cancer

    Volume 131, Issue 12, 15 December 2012, Pages: 2961–2969, Zakaria Ezzoukhry, Christophe Louandre, Eric Trécherel, Corinne Godin, Bruno Chauffert, Sébastien Dupont, Momar Diouf, Jean-Claude Barbare, Jean-Claude Mazière and Antoine Galmiche

    Version of Record online : 30 APR 2012, DOI: 10.1002/ijc.27604

  14. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  15. You have free access to this content
    Sorafenib rechallenge in patients with metastatic renal cell carcinoma

    BJU International

    Volume 110, Issue 6b, September 2012, Pages: E228–E234, Masahiro Nozawa, Yutaka Yamamoto, Takafumi Minami, Nobutaka Shimizu, Yuji Hatanaka, Hidenori Tsuji and Hirotsugu Uemura

    Version of Record online : 14 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10905.x

  16. Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia

    Pediatric Blood & Cancer

    Volume 62, Issue 6, June 2015, Pages: 1048–1054, Katherine Tarlock, Bill Chang, Todd Cooper, Thomas Gross, Sumit Gupta, Steven Neudorf, Kathleen Adlard, Phoenix A. Ho, Suzanne McGoldrick, Tanya Watt, Tina Templeman, India Sisler, Amy Garee, Blythe Thomson, Ann Woolfrey, Elihu Estey, Soheil Meshinchi and Jessica A. Pollard

    Version of Record online : 8 FEB 2015, DOI: 10.1002/pbc.25437

  17. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  18. You have free access to this content
    Sorafenib, a multikinase inhibitor, is effective in vitro against non-hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin

    American Journal of Hematology

    Volume 87, Issue 3, March 2012, Pages: 277–283, Vijay Ramakrishnan, Michael Timm, Jessica L. Haug, Teresa K. Kimlinger, Timothy Halling, Linda E. Wellik, Thomas E. Witzig, S. Vincent Rajkumar, Alex A. Adjei and Shaji Kumar

    Version of Record online : 21 DEC 2011, DOI: 10.1002/ajh.22263

  19. Safety and Pharmacokinetics of Sorafenib Combined With Capecitabine in Patients With Advanced Solid Tumors: Results of a Phase 1 Trial

    The Journal of Clinical Pharmacology

    Volume 51, Issue 12, December 2011, Pages: 1674–1684, Dr Ahmad Awada, Dr Thierry Gil, Dr Nicolas Whenham, Dr Julie Van Hamme, Dr Tatiana Besse-Hammer, Dr Erich Brendel, Dr Heinz Delesen, Dr Miranda C. Joosten, Dr Chetan D. Lathia, Dr Bienvenu A. Loembé, Dr Martine Piccart-Ghebart and Dr Alain Hendlisz

    Version of Record online : 12 MAR 2013, DOI: 10.1177/0091270010386226

  20. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 12, December 2013, Pages: 1834–1841, Daisuke Miyaki, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Ayako Urabe, Keiichi Masaki, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Takashi Nakahara, Tomokazu Kawaoka, Akira Hiramatsu, Shoichi Takahashi, Masaki Ishikawa, Hideaki Kakizawa, Kazuo Awai and Kazuaki Chayama

    Version of Record online : 22 NOV 2013, DOI: 10.1111/jgh.12311